Variable responses to anti–CTLA-4 antibody treatment alone were observed; tumor growth was controlled in 50% of the MC38 tumor–bearing mice with the remaining 50% of mice having tumor growth comparable to control (Fig. 7K). Here, CTLA4 is linked to neoplasm.